本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evotec SE

6.21
0.0000
成交量:- -
成交额:- -
市值:11.01亿
市盈率:-4.91
高:6.21
开:6.21
低:6.21
收:6.21
52周最高:8.58
52周最低:6.21
股本:1.77亿
流通股本:1.29亿
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.2658
每股收益(LYR):-1.1450
净资产收益率:-17.98%
总资产收益率:-2.69%
市净率:1.19
市盈率(LYR):-5.42

数据加载中...

公司资料

公司名字:
Evotec SE
交易所:
PINK LIMITED
成立时间:
1993
员工人数:
4788
公司地址:
Essener Bogen 7,Hamburg,Hamburg,Germany
邮编:
22419
传真:
- -
简介:
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including BoehringerIngelheim, CHDI, Genentech, Medimmune/AstraZeneca, Novartis and Ono Pharmaceutical. In addition, the Company has existing development partnerships and product candidates both in clinical and preclinical development. These include partnerships with Boehringer Ingelheim, MedImmune and with Andromeda (Teva) in the field of diabetes and with Roche in the field of Alzheimer's disease. Evotec is built on integrated drug discovery know-how of more than 15 years and is a leading player in the drug discovery field. The Company’s headquarters are located in Hamburg, Germany. Additional major operations are based in Abingdon, UK, Göttingen, Munich, Germany, Thane, India and San Francisco, USA. Evotec has more than 600 employees worldwide.